Return to search

Totient gathers $10m seed

Cambridge, Massachusetts-based Totient, an AI-driven drug discovery company, has secured $10 million in seed funding.

Cambridge, Massachusetts-based Totient, an AI-driven drug discovery company, has secured $10 million in seed funding. Totient’s backers include Mission BioCapital, Sands Capital, Viva Biotech, Kaitai Capital, Tau Ventures and Jonathan Milner.

Source: Press Release